These protective effects are mediated through the regulation of the ERK/CREB signaling pathway, providing valuable insights into the molecular mechanisms underlying neuroprotection and laying the groundwork for therapies targeting neurodegenerative diseases such as AD. The gene discussed is CREB1; the disease is neurodegenerative disease.